SCHEMBL7873709

SCHEMBL7873709

CCN(CC)Cc1ccc(COc2ccc3cc(C(=O)N=C(N)NC)[nH]c3c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.47
FLT3 P36888 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
MAOB P27338 5/20 0.40
ACHE P22303 1/20 0.40
PDGFRB P09619 1/20 0.39
PDGFRA P16234 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
SRD5A2 P31213 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CFD P00746 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7882351 0.93 CFD (0.44) HRH3FLT3L3MBTL1MAOBACHE
SCHEMBL7877734 0.90 FLT3 (0.46) FLT3MAOBACHEPDGFRBPDGFRA
SCHEMBL7877995 0.88 FLT3 (0.47) FLT3MAOBACHEPDGFRBPDGFRA
SCHEMBL7873807 0.88 FLT3 (0.40) FLT3L3MBTL1MAOBACHEPDGFRB
Hydrochloric Acid SCHEMBL7877491 0.86 FLT3 (0.57) FLT3MAOBACHEPDGFRBPDGFRA
SCHEMBL7881488 0.86 HRH3 (0.42) HRH3L3MBTL1MAOBKDM4EALDH1A1
SCHEMBL7879928 0.85 FLT3 (0.46) FLT3MAOBPDGFRBPDGFRAKMT2A
SCHEMBL7882185 0.85 HRH3 (0.41) HRH3L3MBTL1MAOBACHEKDM4E
SCHEMBL7873242 0.85 MAOB (0.45) HRH3FLT3MAOBPDGFRBPDGFRA
SCHEMBL7873681 0.84 KMT2A (0.35) HRH3FLT3MEN1KMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed